The clinical efficacy of perioperative inhalation of budesonide/formoterol fumarate dehydrate for lung cancer patients with COPD

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2013
INTERVENTION: Tiotropium inhalation once daily Tiotropium once daily with budesonide / formoterol combination drug 2 inhalation twice a day CONDITION: lung cancer patients with chronic obstructive pulmonary disease PRIMARY OUTCOME: Lung function SECONDARY OUTCOME: QOL and CT or MRI INCLUSION CRITERIA: 1) Lung cancer patients with COPD(FEV1/FVC<70% in stage I‐III) 2) Patients who is scheduled for a standard surgery for lung cancer with clinical stage IA‐IIB.
Epistemonikos ID: 189cae325fe26fa31864b6c18e341539ac3048a3
First added on: Aug 22, 2024